Williams Riley J, Ranawat Anil S, Potter Hollis G, Carter Timothy, Warren Russell F
Institute for Cartilage Repair, The Hospital for Special Surgery, Weill Cornell Medical College, 535 East 70th Street, New York, NY 10021.
J Bone Joint Surg Am. 2007 Apr;89(4):718-26. doi: 10.2106/JBJS.F.00625.
Osteochondral allograft reconstruction of articular cartilage defects is a well-established cartilage repair strategy. Currently, fresh osteochondral allograft tissue is commercially available to clinicians approximately thirty days following graft harvest. Little clinical information is available on the outcome of patients who have been treated with fresh allografts stored for several weeks or more. The purpose of this study was to prospectively analyze the clinical outcome and graft morphology of patients who received fresh, hypothermically stored, allograft tissue for the treatment of symptomatic chondral and osteochondral defects of the knee.
Nineteen patients with symptomatic chondral and osteochondral lesions of the knee who were treated with fresh osteochondral allografts between 1999 and 2002 were prospectively followed. The mean age at the time of surgery was thirty-four years. Validated outcomes instruments (the Activities of Daily Living Scale and the Short Form-36) were used; all patients must have had a baseline functional score prior to surgery and a minimum two-year follow-up evaluation. All grafts were obtained from commercial vendors; the mean preimplantation storage time of the graft was thirty days (range, seventeen to forty-two days). The mean lesion size was 602 mm(2). Magnetic resonance imaging was used to evaluate the morphologic characteristics of the implanted grafts.
The mean duration of clinical follow-up was forty-eight months (range, twenty-one to sixty-eight months). The mean score (and standard deviation) on the Activities of Daily Living Scale increased from a baseline of 56 +/- 24 to 70 +/- 22 at the time of the final follow-up (p < 0.05). The mean Short Form-36 score increased from a baseline of 51 +/- 23 to 66 +/- 24 at the time of final follow-up (p < 0.005). With the numbers studied, we could not correlate graft storage time, body mass index, lesion size, lesion location, or patient age with the functional outcome scores. At a mean follow-up interval of twenty-five months, cartilage-sensitive magnetic resonance imaging demonstrated that the normal articular cartilage thickness was preserved in eighteen implanted grafts, and allograft cartilage signal properties were isointense relative to normal articular cartilage in eight of the eighteen grafts. Osseous trabecular incorporation of the allograft was complete or partial in fourteen patients and poor in four patients. Complete or partial trabecular incorporation positively correlated with Short Form-36 scores at the time of follow-up (r = 0.487, p < 0.05).
Fresh osteochondral allografts that were hypothermically stored between seventeen and forty-two days were effective in the short term both structurally and functionally in reconstructing symptomatic chondral and osteochondral lesions of the knee.
Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.
关节软骨缺损的骨软骨异体移植重建是一种成熟的软骨修复策略。目前,临床医生可在移植物获取后约30天获得新鲜的骨软骨异体移植组织。关于接受储存数周或更长时间的新鲜异体移植物治疗的患者的结局,几乎没有临床信息。本研究的目的是前瞻性分析接受新鲜、低温保存的异体移植组织治疗膝关节有症状软骨和骨软骨缺损患者的临床结局和移植物形态。
对1999年至2002年间接受新鲜骨软骨异体移植治疗膝关节有症状软骨和骨软骨病变的患者进行前瞻性随访。手术时的平均年龄为34岁。使用经过验证的结局评估工具(日常生活活动量表和简短健康调查问卷-36);所有患者在手术前必须有基线功能评分,并至少进行两年的随访评估。所有移植物均从商业供应商处获得;移植物植入前的平均储存时间为30天(范围为17至42天)。平均病变大小为602平方毫米。使用磁共振成像评估植入移植物的形态特征。
临床随访的平均持续时间为48个月(范围为21至68个月)。日常生活活动量表的平均评分(及标准差)从基线时的56±24增加到最后随访时的70±22(p<0.05)。简短健康调查问卷-36的平均评分从基线时的51±23增加到最后随访时的66±24(p<0.005)。根据所研究的数量来看,我们无法将移植物储存时间、体重指数、病变大小、病变位置或患者年龄与功能结局评分相关联。在平均25个月的随访间隔时,对软骨敏感的磁共振成像显示,18个植入移植物中正常关节软骨厚度得以保留,18个移植物中有8个的异体移植软骨信号特性与正常关节软骨等信号。14例患者的异体移植骨小梁完全或部分融合,4例患者融合较差。骨小梁完全或部分融合与随访时的简短健康调查问卷-36评分呈正相关(r=0.487,p<0.05)。
在17至42天之间低温保存的新鲜骨软骨异体移植物在短期内在结构和功能上对重建膝关节有症状软骨和骨软骨病变有效。
治疗性IV级。有关证据水平的完整描述,请参阅作者须知。